Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 4 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
li alan tai[Author]
(2 results)?
A brand new era of cancer immunotherapy: breakthroughs and challenges.
Chin Med J (Engl). 2021 May 19;134(11):1267-1275. doi: 10.1097/CM9.0000000000001490.
Chin Med J (Engl). 2021.
PMID: 34039862
Free PMC article.
Review.
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
Bai RL, Wang NY, Zhao LL, Zhang YF, Cui JW.
Bai RL, et al.
Hepatobiliary Pancreat Dis Int. 2022 Feb;21(1):10-24. doi: 10.1016/j.hbpd.2021.08.012. Epub 2021 Sep 8.
Hepatobiliary Pancreat Dis Int. 2022.
PMID: 34538570
Review.
Item in Clipboard
Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma.
Liu XL, Bai RL, Chen X, Zhao YG, Wang X, Ma KW, Tian HM, Han FJ, Liu ZL, Yang L, Li W, Gai F, Cui JW.
Liu XL, et al. Among authors: bai rl.
Chin Med J (Engl). 2021 Sep 30;134(20):2430-2437. doi: 10.1097/CM9.0000000000001760.
Chin Med J (Engl). 2021.
PMID: 34669636
Free PMC article.
Item in Clipboard
Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer.
Li WQ, Li LY, Bai RL, Qian L, Chen NF, Cui JW.
Li WQ, et al. Among authors: bai rl.
Chin Med J (Engl). 2020 Nov 5;133(21):2630-2632. doi: 10.1097/CM9.0000000000001120.
Chin Med J (Engl). 2020.
PMID: 33009031
Free PMC article.
No abstract available.
Item in Clipboard
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options.
Cui JW, Zhou Q, Lu S, Cheng Y, Wang J, Bai RL, Li WQ, Qian L, Chen XY, Fan Y, Huang C, Liu XQ, Tu HY, Yang JJ, Zhang L, Zhou JY, Zhong WZ, Wu YL.
Cui JW, et al. Among authors: bai rl.
Transl Lung Cancer Res. 2021 Aug;10(8):3594-3607. doi: 10.21037/tlcr-21-388.
Transl Lung Cancer Res. 2021.
PMID: 34584859
Free PMC article.
Item in Clipboard
Cite
Cite